A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...
RBC Capital analyst Shagun Singh initiated coverage of Insulet (PODD) with an Outperform rating and $340 price target The firm says Insulet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback